Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence
出版年份 2015 全文链接
标题
Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence
作者
关键词
-
出版物
Scientific Reports
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-06-16
DOI
10.1038/srep11086
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gamma Secretase-Activating Protein Is a Substrate for Caspase-3: Implications for Alzheimer’s Disease
- (2015) Jin Chu et al. BIOLOGICAL PSYCHIATRY
- A common GSAP promoter variant contributes to Alzheimer's disease liability
- (2014) Min Zhu et al. NEUROBIOLOGY OF AGING
- Novel lipid signaling pathways in Alzheimer's disease pathogenesis
- (2013) Phillip F. Giannopoulos et al. BIOCHEMICAL PHARMACOLOGY
- Imatinib methanesulfonate reduces hippocampal amyloid-beta and restores cognitive function following repeated endotoxin exposure
- (2013) Marielle K. Weintraub et al. BRAIN BEHAVIOR AND IMMUNITY
- 5-Lipoxygenase Inhibitor Zileuton Inhibits Neuronal Apoptosis Following Focal Cerebral Ischemia
- (2013) Song-sheng Shi et al. INFLAMMATION
- Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease
- (2013) P F Giannopoulos et al. MOLECULAR PSYCHIATRY
- 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of alzheimer disease
- (2012) Jin Chu et al. ANNALS OF NEUROLOGY
- Purification and Characterization of the Human γ-Secretase Activating Protein
- (2012) Catherine L. Deatherage et al. BIOCHEMISTRY
- Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice
- (2012) Jin Chu et al. Molecular Neurodegeneration
- Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimer's Disease
- (2012) Sam Gandy NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains
- (2011) J. Satoh et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Overexpression of 5-Lipoxygenase Increases the Neuronal Vulnerability of PC12 Cells to Aβ42
- (2011) Ze-Jian WANG et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- 5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo
- (2010) Jin Chu et al. ANNALS OF NEUROLOGY
- Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease
- (2010) Gen He et al. NATURE
- 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor α-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice
- (2009) Marcos Martínez-Clemente et al. HEPATOLOGY
- Increased 5-Lipoxygenase Immunoreactivity in the Hippocampus of Patients With Alzheimer's Disease
- (2008) Milos D. Ikonomovic et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Inhibition and modulation of γ-secretase for Alzheimer’s disease
- (2008) Michael S. Wolfe Neurotherapeutics
- 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer’s disease
- (2007) Omidreza Firuzi et al. FASEB JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started